The SNS Insider report has unveiled substantial data showing a promising future in the Infection Surveillance Solutions Market. In 2022, the market was valued at USD 616.08 million and forecasts indicate it’s expected to grow to USD 1911 million by 2030. With the compound annual growth rate (CAGR) predicted at 15.2%, this surge is expected to occur from 2023 to 2030.
The report illuminates that the development is anchored in the escalating ability of IT systems to process healthcare analytics efficiently, spurred by technological advancements. This has created a path for analytical solutions, optimizing surveillance in healthcare, and improving the management of infections.
Unpacking the constituting parts of the market unveils an amalgamation of data analytics, surveillance technologies, and intricate software solutions. This mix aims to fashion an integrated platform for real-time observation and diagnosis of infections through monitoring patient data, clinical processes, and laboratory results. Moreover, the Infection Surveillance Solutions program bolsters the healthcare industry’s move towards a dynamic, data-based model that promotes patient safety and quality improvement.
Peering into future opportunities, countries with emerging economies such as India, China, Brazil, Russia, and regions in Latin America and Southeast Asia are earmarked for significant expansion in the infection surveillance solutions market. Contributing factors include the enormous population size in these regions, growing public demand for superior hospital care, amplified healthcare costs tied to healthcare-associated infections, the emergence of multidrug-resistant pathogens, and government initiatives.
The report also detailed segmentation of the market for infection control solutions into surgical site infections, bloodstream infections, urinary tract infections, among other illnesses. As of 2021, urinary tract infections (UTIs) held the lion’s share of the market and this hold is projected to continue until 2032.
The beneficiaries (end-users) of the market can be segmented into hospitals and long-term care facilities. In 2021, hospitals were the greatest contributors globally, given that they report more hospital-acquired infections as compared to other institutions. Improved patient care is a primary focus for hospitals and they also dedicate a considerable amount of time to this cause. Notably, electronic surveillance equipment is utilized by 45.5% of hospitals, a number likely to surge with the demand for more software tools for expedited disease pattern examination.
Looking at regional development, North America and Europe are projected to hold the most substantial market share through 2025, propelled by stringent government initiatives in the US and Canada and a rising incidence of Healthcare-Associated Infections (HAIs). The Asia-Pacific market is also tipped to see considerable growth due to improved healthcare infrastructure and increased medical tourism, despite hindrances such as high system costs and low awareness about the availability of advanced technologies.
The report concludes by enumerating latest developments in the Infection Surveillance Solutions Market, particularly the BD Foundation’s commitment to support healthcare in Africa and VigiLanz’s introduction of an innovative audit solution. Set for substantial growth, it’s clear the Infection Surveillance Solutions Market is pivotal to a safer healthcare future.